Journal of Natural Products
Article
nylon membrane, and dried. L-Cysteine methyl ester (1 mg) and
pyridine (100 μL) were added, and the mixture was heated at 60 °C
under reflux for 1 h. A solution of phenyl isothiocyanate in pyridine
(10 mg/mL; 100 μL) was added, and the mixture refluxed at 60 °C for
another hour. The reaction mixture was immediately analyzed by RP-
HPLC (Gemini C18 column; Phenomenex, 250 × 4.6 mm; 5 μm)
using a gradient of MeCN and H2O, 10% to 90% MeCN over 70 min,
flow rate of 1.0 mL/min, and UV detection at 250 nm. D-(+)-Glucose
was used as a reference standard. A blank reaction was performed but
without the addition of the sample or reference sugar. The hydrolysis
and derivatization steps were carried out using 10 mg of the crude
extract by the same procedure to investigate the presence of other
sugar units in the crude extract.
ACKNOWLEDGMENTS
■
This work was funded by CNPq, Brazil (SWE grant for
P.R.V.C., 200972/2011-01), in part, by the United States
Department of Agriculture, ARS, Specific Cooperative Agree-
ment number 58-6408-2-009, and from the European
Community’s Seventh Framework Programme [FP7-2007-
2013] under grant agreement number HEALTH-F4-2011-
281608. CNPq also provided a research fellowship for F.C.B.
(307649/2009-1). We thank Dr. D. Rosado, Department of
Chemistry and Biochemistry at Mississippi College, Clinton,
MS, for the use of the JASCO J-815 spectrometer.
Phloroglucinolysis Reaction.15,16 Compound 1 (5 mg) and
phloroglucinol hydrate (10 mg) were added to a round-bottom
flask, and the mixture was stirred at 60 °C in EtOAc/0.1 N HCl (1:4)
for 4 h. The mixture was extracted with EtOAc (6 × 15 mL), the
organic phase dried over Na2SO4, and the solvent removed under
vacuum at 40 °C. The products were purified by RP-HPLC over a
Phenomenex ODS column (10.0 × 250 mm i.d., 5.0 μm), using a
gradient of MeCN and H2O, with 10% to 65% MeCN over 40 min, a
flow rate of 1.0 mL/min, and UV detection at 280 nm. Compounds 3
and 4 were identified by NMR data as the dimers formed by the
cleavage of side chains 2 and 1 in mansoin A (1), respectively.
TNF-α Production Assay. THP-1 cells (ATCC TIB-202) were
cultivated in RPMI 1640 (Sigma-Aldrich, St. Louis, MO, USA)
medium supplemented with 0.05 mM 2-mercaptoethanol, 10% FBS,
100 U/mL penicillin, and 100 μg/mL gentamicin at 37 °C in an
atmosphere containing 5% CO2. The medium was renewed twice a
week when the cell concentration reached 1.0 × 106 cells/mL. The
cells were transferred to a 96-well microplate at a concentration of 100
000 cells per well and incubated for 18 h with RPMI supplemented
with 1% SFB to initiate serum starvation, which was kept throughout
the experiment. The cells were pretreated with mansoins A (1) and B
(2) at concentrations from 3.9 to 250 μmol/L for 3 h. LPS (Sigma-
Aldrich), added at a concentration of 200 ng/mL, was employed as the
inflammatory stimulus. The plate was incubated at 37 °C overnight.
After this period, the plate was centrifuged (1.800g, 5 min, 16 °C), the
supernatant collected, and TNF-α release measured using the
cytokine-specific sandwich quantitative ELISA according to the
manufacturer’s instructions (TNF-α duo set, DY210, R&D Systems,
Minneapolis, MN, USA). The cell viability was evaluated for the test
samples employing the MTT method27 using untreated cells as the
reference for viability. Samples were considered nontoxic for the THP-
1 cell line when cell viability was higher than 90%. The percentage of
TNF-α inhibition was calculated from the ratio between the observed
TNF-α amount secreted by treated cells (pg/mL) and the baseline
secretion of TNF-α (pg/mL) observed for the solvent control (0.1%
DMSO). The statistical significance of differences was calculated
employing the software GraphPad Prism, version 5.0 (GraphPad
Software Inc., San Diego, CA, USA), using one-way ANOVA followed
by Tukey’s post hoc test for multiple comparisons. Results were
considered different when p < 0.05. IC50 values were determined by
nonlinear regression using GraphPad Prism, version 5.0. All the
experiments were performed in triplicate.
REFERENCES
■
(1) Gentry, A. H. Flora Neotrop. 1980, 25, 1−130.
(2) Zoghbi, M. G. B.; Oliveira, J.; Guilhon, G. M. S. P. Brazil. J.
Pharmacog. 2009, 19, 795−804.
(3) De Miranda, C. S. A.; Reinhard, K. J. Mem. Inst. Oswaldo Cruz
2003, 98, 207−211.
̂ ́
(4) Silva, D. M. Perfil Metabolomico e Farmacologico de Mansoa
hirsuta DC. (Bignoniaceae) por RMN 1H. Ph.D. Thesis, Universidade
Federal de Alagoas, Maceio, AL, Brazil, 2010, p 133.
(5) Rocha, A. D.; Oliveira, A. B; Souza-Filho, J. D.; Lombardi, J. A.;
Braga, F. C. Phytother. Res. 2004, 18, 463−467.
(6) Braga, F. C.; Wagner, H.; Lombardi, J. A.; Oliveira, A. B.
Phytomedicine 2000, 7, 245−250.
(7) Campana, P. R. V.; Braga, F. C.; Cortes, S. F. Phytomedicine 2009,
16, 456−461.
(8) Endringer, D. C.; Valadares, Y. M.; Campana, P. R. V.; Campos, J.
J.; Guimaraes, K. G.; Pezzuto, J. M.; Braga, F. C. Phytother. Res. 2010,
̃
24, 928−933.
(9) Croft, M.; Benedict, C. A.; Ware, C. F. Nat. Rev. 2013, 12, 147−
168.
(10) Khanna, D.; Sethi, G.; Ahn, K. S.; Pandey, M. K.;
Kunnumakkara, A. B.; Sung, B.; Aggarwal, A.; Aggarwal, B. B. Curr.
Opin. Pharmacol. 2007, 7, 344−351.
(11) Campana, P. R. V.; Mansur, D. S.; Gusman, G. S.; Ferreira, D.;
Teixeira, M. M.; Braga, F. C. Manuscript in preparation.
(12) Mabry, T. J.; Markham, K. R.; Thomas, M. B. In The Systematic
Identification of Flavonoids; Springer-Verlag: Berlin, 1970; Part II, pp
165−226.
(13) Moawad, A.; Hetta, M.; Zjawiony, J. K.; Jacob, M. R.; Hifnawy,
M.; Marais, J. P. J.; Ferreira, D. Planta Med. 2010, 76, 796−802.
(14) Tanaka, T.; Nakashima, T.; Ueda, T.; Tomii, K.; Kouno, I.
Chem. Pharm. Bull. 2007, 55, 899−901.
(15) Foo, L. Y; Porter, L. J. J. Chem. Soc., Perkin Trans. 1 1978,
1186−1190.
(16) Kennedy, J. A.; Jones, G. P. J. Agric. Food Chem. 2001, 49,
1740−1746.
(17) Gaffield, W. Tetrahedron 1970, 26, 4093−4108.
(18) Wilhelm-Mouton, A.; Bonnet, S. L.; Ding, Y.; Li, X. C.; Ferreira,
D.; Van der Westhuizen, J. H. J. Photochem. Photobiol. 2012, 227, 18−
24.
(19) Weiss, T.; Shalit, I.; Blau, H.; Werber, S.; Haplerin, D.; Levitov,
A.; Fabian, I. Antimicrob. Agents Chemother. 2004, 48, 1974.
(20) Hernandez, I.; Alegre, L.; Breusegemm, F. V.; Munne-Bosch, S.
Trends Plant Sci. 2009, 14, 125−132.
ASSOCIATED CONTENT
* Supporting Information
1D- and 2D-NMR spectra and HRMS of compounds 1 and 2
■
S
(21) Atmani, D.; Chaher, N.; Atmani, D.; Berboucha, M.; Debbache,
N.; Boudaoud, H. Curr. Nutr. Food Sci. 2009, 5, 225−237.
́ ́
(22) Tunon, M. J.; García-Mediavilla, M. V.; Sanchez-Campos, S.;
̃
AUTHOR INFORMATION
Corresponding Author
*Tel: +55 31 3409-6951. Fax: +55 31 3409-6935. E-mail:
́
Gonzalez-Gallego, J. Curr. Drug Metab. 2009, 10, 256−271.
■
(23) Ferreira, D.; Slade, D.; Marais, J. P. J. In Flavonoids: Chemistry,
Biochemistry and Applications; Andersen, O.; Markham, K. R., Eds.;
CRC Press: Boca Raton, FL, 2006; pp 553−616.
(24) Ferreira, D.; Slade, D.; Marais, J. P. J. In Flavonoids: Chemistry,
Biochemistry and Applications; Andersen, O.; Markham, K. R., Eds.;
CRC Press: Boca Raton, FL, 2006; pp 1101−1128.
Notes
The authors declare no competing financial interest.
829
dx.doi.org/10.1021/np400929g | J. Nat. Prod. 2014, 77, 824−830